XML 100 R86.htm IDEA: XBRL DOCUMENT v3.22.4
STOCK-BASED COMPENSATION - Stock-Based Compensation Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Jan. 05, 2021
Mar. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Stock-based compensation          
Unrecognized compensation cost     $ 345,500    
Weighted average period for recognition of unrecognized compensation cost     2 years 3 months 29 days    
Stock-based compensation     $ 206,823 $ 253,063 $ 152,906
Thrive          
Stock-based compensation          
Stock-based compensation       19,000  
Non-cash stock-based compensation expense $ 65,000        
Thrive | General and administrative          
Stock-based compensation          
Non-cash stock-based compensation expense   $ 86,200   $ 86,200  
Stock Options | Thrive          
Stock-based compensation          
Accelerated vesting (in shares)       139,096  
Stock Options | Genomic Health Inc          
Stock-based compensation          
Accelerated vesting (in shares)         83,593
Restricted Shares and RSUs | Thrive          
Stock-based compensation          
Accelerated vesting (in shares)       58,171  
Restricted Shares and RSUs | Genomic Health Inc          
Stock-based compensation          
Accelerated vesting (in shares)         93,770
Non-cash stock-based compensation expense         $ 9,700